Nutra Pharma Corp (NPHC) - Financial and Strategic SWOT Analysis Review

Nutra Pharma Corp (NPHC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the companys businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the companys key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description A detailed description of the companys operations and business divisions.
- Corporate strategy Analysts summarization of the companys business strategy.
- SWOT Analysis A detailed analysis of the companys strengths, weakness, opportunities and threats.
- Company history Progression of key events associated with the company.
- Major products and services A list of major products, services and brands of the company.
- Key competitors A list of key competitors to the company.
- Key employees A list of the key executives of the company.
- Executive biographies A brief summary of the executives employment history.
- Key operational heads A list of personnel heading key departments/functions.
- Important locations and subsidiaries A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Nutra Pharma Corp (Nutra Pharma) acquires, licenses and commercializes pharmaceutical products, technologies, homeopathic drugs and ethical drugs for managing cancer, neurological disorders, autoimmune and infectious diseases, including human Immunodeficiency virus (HIV), multiple sclerosis (MS), adrenomyeloneuropathy (AMN) and pain. It also markets over-the-counter (OTC) pain management products under the brands Nyloxin and Pet Pain-Away. The companys wholly owned subsidiaries include Designer Diagnostics, which markets and sells rapid diagnostics test kits for infectious diseases; and ReceptoPharm, which develops proprietary therapeutic protein products for the prevention and treatment of viral and neurological diseases. Nutra Pharma is headquartered in Coral Springs, Florida, the US.

Nutra Pharma Corp Key Recent Developments

Mar 08,2018: Nutra Pharma Announces Corporate Updates
Feb 21,2018: Nutra Pharma Files Provisional Patent for Nerve Agent Counter Measures
Jan 25,2018: Nutra Pharma Unveils Updated Websites
Jun 21,2017: Nutra Pharma Announcing Launch of Luxury Feet
May 23,2017: Nutra Pharma Announces Collaboration with the International Security Group for Development of Nerve Agent Counter Measures

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The companys core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company


List of Tables 5
List of Figures 5
Section 1 - About the Company 6
Nutra Pharma Corp - Key Facts 6
Nutra Pharma Corp - Key Employees 7
Nutra Pharma Corp - Key Employee Biographies 8
Nutra Pharma Corp - Major Products and Services 9
Nutra Pharma Corp - History 10
Nutra Pharma Corp - Company Statement 14
Nutra Pharma Corp - Locations And Subsidiaries 15
Head Office 15
Other Locations & Subsidiaries 15
Section 2 Company Analysis 16
Company Overview 16
Nutra Pharma Corp - Business Description 16
Product Category: Luxury Feet 16
Overview 16
Product Category: Nyloxin 16
Overview 16
Performance 16
Product Category: Pet Pain-Away 16
Overview 16
Performance 17
R&D Overview 17
Nutra Pharma Corp - Corporate Strategy 18
Nutra Pharma Corp - SWOT Analysis 19
SWOT Analysis - Overview 19
Nutra Pharma Corp - Strengths 19
Nutra Pharma Corp - Weaknesses 20
Nutra Pharma Corp - Opportunities 21
Nutra Pharma Corp - Threats 22
Nutra Pharma Corp - Key Competitors 23
Section 3 Company Financial Ratios 24
Financial Ratios - Capital Market Ratios 24
Financial Ratios - Annual Ratios 25
Performance Chart 27
Financial Performance 27
Financial Ratios - Interim Ratios 28
Financial Ratios - Ratio Charts 29
Section 4 Companys Lifesciences Financial Deals and Alliances 30
Nutra Pharma Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 30
Nutra Pharma Corp, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 31
Nutra Pharma Corp, Recent Deals Summary 32
Section 5 Companys Recent Developments 33
Mar 08, 2018: Nutra Pharma Announces Corporate Updates 33
Feb 21, 2018: Nutra Pharma Files Provisional Patent for Nerve Agent Counter Measures 34
Jan 25, 2018: Nutra Pharma Unveils Updated Websites 35
Jun 21, 2017: Nutra Pharma Announcing Launch of Luxury Feet 36
May 23, 2017: Nutra Pharma Announces Collaboration with the International Security Group for Development of Nerve Agent Counter Measures 37
Section 6 Appendix 38
Methodology 38
Ratio Definitions 38
About GlobalData 42
Contact Us 42
Disclaimer 42

List Of Tables

List of Tables
Nutra Pharma Corp, Key Facts 6
Nutra Pharma Corp, Key Employees 7
Nutra Pharma Corp, Key Employee Biographies 8
Nutra Pharma Corp, Major Products and Services 9
Nutra Pharma Corp, History 10
Nutra Pharma Corp, Subsidiaries 15
Nutra Pharma Corp, Key Competitors 23
Nutra Pharma Corp, Ratios based on current share price 24
Nutra Pharma Corp, Annual Ratios 25
Nutra Pharma Corp, Annual Ratios (Cont...1) 26
Nutra Pharma Corp, Interim Ratios 28
Nutra Pharma Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 30
Nutra Pharma Corp, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 31
Nutra Pharma Corp, Recent Deals Summary 32
Currency Codes 38
Capital Market Ratios 38
Equity Ratios 39
Profitability Ratios 39
Cost Ratios 40
Liquidity Ratios 40
Leverage Ratios 41
Efficiency Ratios 41

List Of Figures

List of Figures
Nutra Pharma Corp, Performance Chart (2013 - 2017) 27
Nutra Pharma Corp, Ratio Charts 29
Nutra Pharma Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 30
Nutra Pharma Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 31

Nutra Pharma Corp (NPHC) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Nutra Pharma Corp (Nutra Pharma) acquires, licenses and commercializes pharmaceutical products, technologies, homeopathic drugs and ethical drugs for managing cancer, neurological disorders, autoimmune and infectious diseases, including human Immunodeficiency virus

USD 250 View Report

Nutra Pharma Corp (NPHC) - Pharmaceuticals and Healthcare - Deals and Alliances Profile

Nutra Pharma Corp (Nutra Pharma) acquires, licenses and commercializes pharmaceutical products, technologies, homeopathic drugs and ethical drugs for managing cancer, neurological disorders, autoimmune and infectious diseases, including human Immunodeficiency virus

USD 250 View Report

Mitsubishi Tanabe Pharma Corp - Strategic SWOT Analysis Review

Mitsubishi Tanabe Pharma Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the companys history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis,

USD 125 View Report

Nutra Pharma Corp (NPHC) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Nutra Pharma Corp (Nutra Pharma) acquires, licenses and commercializes pharmaceutical products, technologies, homeopathic drugs and ethical drugs for managing cancer, neurological disorders, autoimmune and infectious diseases, including human Immunodeficiency virus

USD 250 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available